Individual provider · Type 1 NPI
David R. Alaniz Ii, PHARM D
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist · Corpus Christi, TX
Practice location
3205 S Alameda St
Corpus Christi, TX 78404-2507
Mailing address
4625 Helen St
Corpus Christi, TX 78415-1643
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Primary | 1835P0018X | 67686 (TX) |
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist: Pharmacist Clinician/Clinical Pharmacy Specialist is a pharmacist with additional training and an expanded scope of practice that may include prescriptive authority, therapeutic management, and disease management.
4 other providers at this address
Other pharmacist clinician (phc)/ clinical pharmacy specialist providers in Corpus Christi
- Lola OlagunjuPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1114586930
- Arezo Noormohammadi, PharmDPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1124375803
- Karlye Lynette Pesci Trevino, PharmD, BCPSPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1255716551
- Jehu Tomas Gracia, PharmDPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1407425937
- Adriana CampaPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1467041228
- William PiercePharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1629499587
- Christy L. Berry, RPHPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1720361991
- Rolando Gonzalez, PharmDPharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Corpus Christi, TX NPI 1972902757
About NPI 1508583139
David R. Alaniz Ii, PHARM D's National Provider Identifier is 1508583139, issued on Oct 25, 2022. The primary taxonomy on file is Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist (1835P0018X), and the practice location is in Corpus Christi, TX. The record was last updated on Oct 25, 2022.